Clofibric acid increases the undirectional chiral inversion of ibuprofen in rat liver preparations.
1. The formation of (S)-ibuprofen from (R)-ibuprofen was monitored in perfused rat livers and in rat hepatocytes and the rate constants calculated. 2. Pre-treatment of animals for three days with clofibric acid markedly increased the (R)-to-(S) inversion of ibuprofen in both preparations. In contrast, clofibric acid did not elicit such a reaction with flurbiprofen, an analogue that does not undergo inversion under control conditions. 3. An increase in the chiral inversion was also seen when clofibric acid was added to the perfusion medium or to hepatocyte suspensions. In the latter system this increase was shown to be concentration dependent. 4. Pre-treatment of rat combined with addition of clofibric acid to the perfusion medium produced a cumulative stimulation of (R)-to-(S) inversion of ibuprofen. 5. Clofibric acid added to hepatocyte suspensions transiently increased intracellular concentrations of coenzyme A whereas (R)-ibuprofen transiently decreased CoA concentrations. The two effects cancelled each other upon co-incubation of the two compounds. 6. It is postulated that the metabolic interaction observed between clofibric acid and (R)-ibuprofen may be due to changes in intracellular concentrations of CoA.
Roy-de Vos
M
M
Institut de chimie thérapeutique, Université de Lausanne, BEP, Switzerland.
Mayer
J M
JM
Etter
J C
JC
Testa
B
B
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002995:Clofibric Acid / Q000008:administration & dosage / Q000494:pharmacology*; D003065:Coenzyme A / Q000378:metabolism; D004347:Drug Interactions; D005480:Flurbiprofen / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007052:Ibuprofen / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D013237:Stereoisomerism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; D005480:Flurbiprofen; D003065:Coenzyme A; D007052:Ibuprofen